S. 2888Senate117th Congress (2021-2023)In Committee

U.S. Air Travel Public Safety Act

Introduced September 29, 2021

AI-Generated Summary

Updated February 8, 2026 at 7:02 AM UTC

The U.S. Air Travel Public Safety Act aims to lower COVID‑19 risk for passengers, crew, and airport staff by requiring proof of vaccination or a negative test/recovery documentation before boarding domestic flights. It applies to all passenger‑carrying airlines, including foreign carriers, that operate flights within the United States, and is overseen by the Department of Health and Human Services in coordination with the FAA.

Key Provisions

  • HHS, consulting with the FAA, must create national vaccination verification standards that covered airlines must follow for all flights departing and arriving in the United States.
  • Passengers may board only if they provide documentation showing they are fully vaccinated, or they attest under penalty of perjury that they meet CDC travel recommendations by presenting a negative COVID‑19 test taken within a specified time frame or proof of recent recovery from infection.
  • HHS must issue interim final rules implementing these standards within 30 days of the law’s enactment, including a list of individuals and organizations exempt from the requirements.
  • The law defines key terms such as “covered air carrier,” “covered flight,” “qualifying test result,” and “documentation of recovery” to clarify who must comply and what evidence is acceptable.
  • The CDC’s Advisory Committee on Immunization Practices must review transmission data and issue vaccine use recommendations within 30 days of enactment.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

1 earlier action
SenateIntro Referral Latest Action

Read twice and referred to the Committee on Commerce, Science, and Transportation. (Sponsor introductory remarks on measure: CR S6782)

September 29, 2021

View full timeline
SenateIntro Referral

Introduced in Senate

September 29, 2021

SenateIntro Referral

Read twice and referred to the Committee on Commerce, Science, and Transportation. (Sponsor introductory remarks on measure: CR S6782)

September 29, 2021

Floor Debate

8 members

What members said about S. 2888 on the floor

3 Republicans5 Democrats
Ron Johnson
Sen. Ron JohnsonR-WI · Sep 29, 2021

Mr. President, I rise in support of Senator Scott's bill. I want to make a few different points. First of all, I don't believe this administration or people who support the mandates are really…

Patrick J. Leahy
Sen. Patrick J. LeahyD-VT · Sep 29, 2021

Mr. President, 10 years ago this month, Congress worked on a broad bipartisan basis to pass the Leahy-Smith America Invents Act, the biggest change to the United States patent laws in half a century.…

Mike Lee
Sen. Mike LeeR-UT · Sep 29, 2021

Mr. President, during this pandemic, the people of the United States have seen the Federal Government intrude into their lives more frequently and more completely than ever before. President Biden…

Rick Scott
Sen. Rick ScottR-FL · Sep 29, 2021

Mr. President, the past 18 months have been trying for our Nation. Thankfully, the vaccine has brought normalcy back to the lives of many Americans. In record time, thanks to the hard work of the…

Dianne Feinstein
Sen. Dianne FeinsteinD-CA · Sep 29, 2021

Mr. President, I rise today to introduce the U.S. Air Travel Public Safety Act. This bill would require airline passengers flying domestically to provide proof that they are fully vaccinated and also…

Show 4 more
Dianne Feinstein
Sen. Dianne FeinsteinD-CA · Sep 29, 2021

Mr. President, I rise today to introduce the U.S. Air Travel Public Safety Act. This bill would require airline passengers flying domestically to provide proof that they are fully vaccinated and also…

Mazie K. Hirono
Sen. Mazie K. HironoD-HI · Sep 29, 2021

Mr. President, I rise today to introduce the Coffee Plant Health Initiative Amendments Act, a bill that allows the Secretary of Agriculture to provide research and extension grants for the purposes…

Alex Padilla
Sen. Alex PadillaD-CA · Sep 29, 2021

Mr. President, I rise to introduce the bipartisan Outdoors for All Act. This legislation would ensure that access to local parks and outdoor recreation is equitable and available to all. The Outdoors…

Tim Kaine
Sen. Tim KaineD-VA · Sep 29, 2021

Mr. President, today, I want to discuss legislation I am introducing, the School Infrastructure Modernization Act. To claim the Federal tax credit for historic preservation, a building renovation…

Bill Text

Latest available legislative text

Reading Mode
Latest
Introduced in SenateIssued September 29, 2021

II

117th CONGRESS

1st Session

S. 2888

IN THE SENATE OF THE UNITED STATES

September 29, 2021

Mrs. Feinstein introduced the following bill; which was read twice and referred to the Committee on Commerce, Science, and Transportation

A BILL

To reduce passenger, crewmember, and airport personnel risk of exposure to COVID–19, decrease the risk of transmission of COVID–19 on board aircraft and to United States destination communities through air travel, and protect children and other vulnerable individuals by preventing further spread of COVID–19 in the United States.

1.

Short title

This Act may be cited as the U.S. Air Travel Public Safety Act.

2.

Domestic air transportation within the United States

(a)

Travel requirement

The Secretary of Health and Human Services (referred to in this section as the Secretary), in consultation with the Federal Aviation Administration, shall develop national vaccination verification standards and procedures in accordance with this section. Such standards and procedures shall require that all covered air carriers require that, before any passenger may board an aircraft for a covered flight, such passenger shall—

(1)

provide the covered air carrier with documentation demonstrating that the passenger is fully vaccinated (as defined by the Secretary or any successor guidance) against the COVID–19 (SARS–CoV–2) novel coronavirus; or

(2)

attest under penalty of perjury that the passenger has adhered to the international travel recommendations and requirements for individuals who are not fully vaccinated (issued by the Centers for Disease Control and Prevention) prior to boarding, including requirements to provide proof of a negative pre-departure qualifying test result for SARS–CoV–2 or, alternatively, written or electronic documentation of recovery from COVID–19 after previous SARS–CoV–2 infection, in accordance with the Centers for Disease Control and Prevention’s testing requirements and applicable guidance.

(b)

Regulations

(1)

In general

The Secretary shall promulgate interim final rules to ensure that the standards and procedures developed under subsection (a) are applied to covered air carriers beginning on the date that is not later than 30 days after the date of enactment of this Act.

(2)

Exception

The interim final rules promulgated under paragraph (1) shall include a list of those categories of individuals and organizations that are exempt from the standards and procedures developed under this section. Such list shall be developed by the Secretary in accordance with the Centers for Disease Control and Prevention’s applicable guidance.

(c)

Definitions

In this section:

(1)

Air carrier

The term air carrier has the meaning given that term in section 40102 of title 49, United States Code.

(2)

Aircraft

The term aircraft has the meaning given that term in section 40102 of title 49, United States Code.

(3)

Airport

The term airport has the meaning given that term in section 40102 of title 49, United States Code.

(4)

Attest; attestation

The terms attest and attestation with respect to a passenger mean the passenger having completed the attestation described in this section. Such attestation may be completed in written or electronic form. The attestation is a statement, writing, entry, or other representation under section 1001 of title 18, United States Code.

(5)

Covered air carrier

The term covered air carrier means—

(A)

any air carrier engaged in passenger-carrying operations; or

(B)

any foreign air carrier authorized to engage in passenger-carrying operations.

(6)

Covered flight

The term covered flight means a flight of a covered carrier that is scheduled to depart from, and arrive at, an airport located in the United States.

(7)

Documentation of recovery

The term documentation of recovery with respect to a passenger means a confirmation that—

(A)

the passenger has presented documentation of a positive test result and a signed letter on official letterhead that contains the name, address, and phone number of a licensed health care provider or public health official stating that the passenger has been cleared for travel;

(B)

the positive test result occurred within the last three months (90 days) preceding the passenger’s flight in the United States, or at such other intervals as specified in guidance issued by the Secretary;

(C)

the personal identifiers (including the name and date of birth) on the positive test result and signed letter match the personal identifiers on the passenger’s passport or other travel documents;

(D)

the test performed was a viral test; and

(E)

the test result states POSITIVE, SARS–CoV–2 RNA DETECTED, SARS–CoV–2 ANTIGEN DETECTED, or COVID–19 DETECTED.

A test marked invalid is not acceptable.
(8)

Foreign air carrier

The term foreign air carrier has the meaning given that term in section 40102 of title 49, United States Code.

(9)

Qualifying test result

The term qualifying test result with respect to a passenger means confirmation that—

(A)

the personal identifiers (including the name and date of birth) on the negative Qualifying Test result match the personal identifiers on the passenger’s passport or other travel documents;

(B)

the specimen was collected within the 3 days (or a lesser number of days if determined appropriate by the Secretary) preceding the flight’s departure;

(C)

the test performed was a viral test; and

(D)

the test result states NEGATIVE, SARS–CoV–2 RNA NOT DETECTED, SARS–CoV–2 ANTIGEN NOT DETECTED, or COVID–19 NOT DETECTED.

A test marked invalid is not acceptable.
(10)

United States

The term United States has the meaning given that term in section 40102 of title 49, United States Code.

3.

Recommendations for COVID–19 vaccine use

Not later than 30 days after the date of enactment of this Act, the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention shall review data on the transmission of COVID–19 in health care settings and among health care personnel in other settings, and develop and make recommendations for COVID–19 vaccine use on the basis of transmission in health care settings and among health care personnel in other settings.